Overexpression of miR‐423 in endometrial cancer cells alters EMT and modulates the expression levels of PTEN and p‐AKT, ultimately promoting the metastasis of endometrial cancer cells.45, 55. This evidence concerns the gene PTEN and endometrial cancer.